Growing Adoption of Self-Testing Kits Drive the Demand for At-Home Testing Kits Market

Home tests are also known as  at-home-use tests or self-tests  which are generally sold over-the-counter (OTC) and allow consumers to test self-collected samples and interpret the results on their own without the help of doctor or other health professionals. At-home testing kits are available for several diseases such as infectious diseases, confirming pregnancy, predicting ovulation cycle, monitoring and checking diabetes and many more. Therefore, the global at-home testing kits market is estimated to increase rapidly in the near future.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-at-home-testing-kits-market

Data Bridge Market Research analyses that the at-home testing kits market is expected to reach USD 13,775.51 million by 2029 from USD 8577.97 million in 2021, growing at a CAGR of 6.10% in the forecast period of 2022 to 2029. The high adoption of moist wound care is projected to propel the growth of the market as they create and maintain a moist environment around the wound, which fosters healing, especially for various chronic injuries such as pressure ulcers, diabetic ulcers, and other slow-healing injuries.

At-Home Testing Kits Market

Growing adoption of self-testing kits is expected to drive the market's growth rate

Previously, the people used to visit hospitals often, even for normal health issues. However, with the rising awareness about several products, now this behavior has changed and has turned the ongoing trends. Now-a-days, individuals prefer to complete their normal tests by using test kits at home before visiting a doctor. The adoption of self-testing has become more prominent due to coronavirus and several restrictions in place. It has become more convenient for consumers because they can quickly and easily know their tests' results at their fingertips.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card and Others), Age (Pediatric, Adult and Geriatric), Sample Type (Urine, Blood, Saliva and Other Sample Types), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket and Online Pharmacies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..

Market Players Covered

Siemens Healthcare GmbH (Germany), F. Hoffmann La-Roche Ltd (Switzerland), Drägerwerk AG & Co. KGaA (Germany), LifeScan IP Holdings (U.S.), Ascensia Diabetes Care Holdings AG (U.S.), Nectar Lifesciences Ltd (India). ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies, Inc. (U.S.), bioLytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S), Siemens (Germany), Abbott (U.S.),

 

Data Points Covered in the Report

In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

Segment Analysis:

The at-home testing kits market is segmented on the basis of test type, type, age, sample type, usage and distribution channels.

  • On the basis of test type, global at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit and other test types.

In 2022, the glucose test segment of product type segment is anticipated to dominate the at-home testing kits market

Glucose test segment is dominating the global at-home testing kits market with the 48.25% market share due to higher cases of dehydration, having comorbid conditions. COVID-19 pandemic has increased the demand of at home testing kit due to the restricted movements and shut down of ongoing activities. This is the major factor which increase the demand of glucose test which are expected to drive the growth of the at home testing kit market.

  • On the basis of type, global at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card and other form types.. In 2022, strip segment is dominating the At-Home Testing Kits market with 50.20% market share due to growing rate of diabetes conditions and increasing governmental initiative for the improvement of health infrastructure
  • On the basis of age, global at-home testing kits market is segmented into pediatric, adult and geriatric. In 2022, Adult segment is dominating the At-Home Testing Kits market with the 57.8% market share due to more exposure to COVID-19 infection, frequently having comorbid conditions, and decreasing quality of life
  • On the basis of sample type, global at-home testing kits market is segmented into urine, blood, saliva and other sample types.  In 2022, blood type is dominating the At-Home Testing Kits market with the 51.7% market share due to the high prevalence of hepatitis C, diabetes, thyroid, anemia, cancer and many others
  • On the basis of usage, the global at-home testing kits market is segmented into disposable and reusable.

In 2022, the disposable segment is projected to hold the largest share of usage segment in the at-home testing kits market

Disposable segment is dominating the At-Home Testing Kits market with 66.1% market share because disposable kits are time-saving , high-efficient, Safe and reliable than other testing kits. The use of disposable testing kits have reduced the chances of disease transmission and decreasing the risk of patient-to-patient contamination.

Major Players

Data Bridge Market Research recognizes the following companies as the major at-home testing kits market players in at-home testing kits market Siemens Healthcare GmbH (Germany), F. Hoffmann La-Roche Ltd (Switzerland), Drägerwerk AG & Co. KGaA (Germany), LifeScan IP Holdings (U.S.), Ascensia Diabetes Care Holdings AG (U.S.), Nectar Lifesciences Ltd (India). ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), Atomo Diagnostics (Australia),

At-Home Testing Kits Market

Market Development

  • In April 2020, Labcorp, which is a U.S. company has created first at-home test kit for the COVID-19 pandemic and it has been also approved by U.S. Food and Drug Administration (FDA). It prices $119 in the United States
  • In November 2020, Quidel Corporation has created a rapid diagnostic test for the detection of coronavirus and has also been received Emergency Use Authorization (EUA) from the FDA for marketing and launching its Sofia 2 SARS Antigen FIA which is a rapid point-of-care test for the COVID-19. It will be utilized for ongoing epidemic and this will aid company to expand their revenues and sales
  • In April 2021, Atomo Diagnostics along with Viatris, had decided to support Unitaid’s quest to increase access to HIV self-testing in middle and low -Income Countries (LMIC). This expansion program will support the supply of HIV self-tests up to one million, with promises to make testing available in approx. 135 countries. This will aid the company to rise its presence in the global market
  • In October 2021, ACON Laboratories, Inc, declared that its Flowflex COVID-19 Antigen Home Test has been approved by the U.S. Food and Drug Administration for the emergency use. This will aid the company to rise its presence in the global market and increase its product portfolio

Regional Analysis

Geographically, the countries covered in the at-home testing kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

As per Data Bridge Market Research analysis:

North America is the dominant region in at-home testing kits market during the forecast period 2022 - 2029

In 2022, North America dominates the at-home testing kits market due to the high healthcare expenditure and the growing awareness regarding at-home testing kits market. The rising adoption of advanced technology, launch of new innovative products, rise in number of cases of chronic disease and the mounting geriatric population are some factor which is expected to further enhance the market's growth rate in this region. 

Asia-Pacific is estimated to be the fastest growing region in at-home testing kits market the forecast period 2022 - 2029

Asia-Pacific is expected to grow during the forecast period due to rapid development of medical facilities and the presence of major market players in emerging economies in this region. Moreover, increasing per-capita income and growing level of healthcare expenditure are expected propel the market's growth rate in this region.

COVID-19 Impact Analysis

The outbreak of COVID-19 had a major impact on the growth of the global at-home testing kits market. The market for at-home testing kits is growing as a significance of the augmented popularity of Do-It-Yourself (DIY) test kits and self-help because of their quick results and convenience. Consumers have more concerns about the reliability of rapid home testing kits, which could obstruct the expansion of at-home testing kits market. Rapid testing kits are used for COVID-19 which were urgently needed by companies to reduce patient deaths and improve patient recovery rates and in return also augmented the rate for at home testing kits market for diabetic patients and those patients having heart problems. This is generating a major market opportunity for the growth of at-home testing kits.

For more detailed information about at-home testing kits market report, click here – https://www.databridgemarketresearch.com/reports/global-at-home-testing-kits-market